GBCS — Selectis Health Income Statement
0.000.00%
- $6.44m
- $42.87m
- $36.78m
Annual income statement for Selectis Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.93 | 20.9 | 29.3 | 40.6 | 36.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.63 | 15.8 | 29.7 | 40.9 | 45.7 |
Operating Profit | 1.3 | 5.1 | -0.378 | -0.333 | -8.96 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.868 | 2.96 | -2.24 | -2.4 | -3.97 |
Net Income After Taxes | -0.868 | 2.96 | -2.24 | -2.4 | -3.97 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.862 | 2.96 | -2.25 | -2.4 | -3.97 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.892 | 2.93 | -2.28 | -2.43 | -4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.304 | 0.453 | -0.951 | -0.779 | -1.31 |